271 related articles for article (PubMed ID: 32349323)
1. Hyaluronan-Metal Gold Nanoparticle Hybrids for Targeted Tumor Cell Therapy.
Sanfilippo V; Caruso VCL; Cucci LM; Inturri R; Vaccaro S; Satriano C
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349323
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid co-functionalized gold nanoparticle complex for the targeted delivery of metformin in the treatment of liver cancer (HepG2 cells).
Kumar CS; Raja MD; Sundar DS; Gover Antoniraj M; Ruckmani K
Carbohydr Polym; 2015 Sep; 128():63-74. PubMed ID: 26005140
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
4. Tunable CD44-specific cellular retargeting with hyaluronic acid nanoshells.
Ebbesen MF; Olesen MT; Gjelstrup MC; Pakula MM; Larsen EK; Hansen IM; Hansen PL; Mollenhauer J; Malle BM; Howard KA
Pharm Res; 2015 Apr; 32(4):1462-74. PubMed ID: 25361867
[TBL] [Abstract][Full Text] [Related]
5. Selective Targeting and Restrictive Damage for Nonspecific Cells by Pulsed Laser-Activated Hyaluronan-Gold Nanoparticles.
Rau LR; Tsao SW; Liaw JW; Tsai SW
Biomacromolecules; 2016 Aug; 17(8):2514-21. PubMed ID: 27439142
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
Sargazi A; Shiri F; Keikha S; Majd MH
Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel.
Song S; Chen F; Qi H; Li F; Xin T; Xu J; Ye T; Sheng N; Yang X; Pan W
Pharm Res; 2014 Apr; 31(4):1032-45. PubMed ID: 24154802
[TBL] [Abstract][Full Text] [Related]
9. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-fabricated nanogold delivery of the inhibitor of apoptosis protein-2 siRNAs inhibits benzo[a]pyrene-induced oncogenic properties of lung cancer A549 cells.
Lin CM; Kao WC; Yeh CA; Chen HJ; Lin SZ; Hsieh HH; Sun WS; Chang CH; Hung HS
Nanotechnology; 2015 Mar; 26(10):105101. PubMed ID: 25693888
[TBL] [Abstract][Full Text] [Related]
11. Development of drug loaded nanoparticles for tumor targeting. Part 1: Synthesis, characterization, and biological evaluation in 2D cell cultures.
El-Dakdouki MH; Puré E; Huang X
Nanoscale; 2013 May; 5(9):3895-903. PubMed ID: 23529646
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells.
Li YF; Zhang HT; Xin L
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1463-1473. PubMed ID: 29858680
[TBL] [Abstract][Full Text] [Related]
13. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells.
Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824
[TBL] [Abstract][Full Text] [Related]
14. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic Acid-Coated Silica Nanoparticles for Targeted Delivery of Nitric Oxide to Cancer Cells.
Grayton QE; Phan TT; Kussatz CC; Schoenfisch MH
ACS Appl Bio Mater; 2024 Jun; 7(6):3796-3809. PubMed ID: 38776418
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Lee JH; Kim K; Kwon IC; Kim DD
Biomaterials; 2011 Oct; 32(29):7181-90. PubMed ID: 21733572
[TBL] [Abstract][Full Text] [Related]
17. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery.
Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L
Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronate coating enhances the delivery and biocompatibility of gold nanoparticles.
Karakocak BB; Liang J; Biswas P; Ravi N
Carbohydr Polym; 2018 Apr; 186():243-251. PubMed ID: 29455984
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
[TBL] [Abstract][Full Text] [Related]
20. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis.
Li W; Guo Z; Zheng K; Ma K; Cui C; Wang L; Yuan Y; Tang Y
Int J Pharm; 2017 Dec; 534(1-2):71-80. PubMed ID: 28958879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
